About Pfizer
Pfizer is a company based in Bothell (United States) founded in 1998 was acquired by Pfizer in March 2023. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 2,404 employees. Pfizer offers products and services including Oncology Treatments, Vaccines, and Internal Medicine Therapies. Pfizer operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Regeneron Pharmaceuticals and MorphoSys, among others.
Products & Services of Pfizer
Pfizer offers a comprehensive portfolio of products and services, including Oncology Treatments, Vaccines, and Internal Medicine Therapies.
Innovative treatments are developed for various cancer types.
Vaccines are created to prevent widespread fatal diseases.
Therapies are designed for obesity and diabetes management.
Funding Insights of Pfizer
- Total Rounds 6
- Last Round Post-IPO — $1B
- Investors Count 9
All 6 funding rounds of Pfizer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $1B | Post-IPO | – | Merck | – |
| Jan 2014 | $9M | Post-IPO | – | – | |
| Jun 2009 | – | Post-IPO | – | – | |
| May 2009 | $11.45M | Post-IPO | – | – | – |
| Jul 2003 | $41M | Post-IPO | – | J P Morgan, Baker Brothers Investments | |
| Jun 1998 | – | Unspecified | – | – |
10 investors in total: 10 institutional.
Investors in Pfizer
Pfizer has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, Pfizer and J P Morgan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are offered to startups by NEA. | – | nea.com | Menlo Park, United States | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
- | – | bakerbrothersinvestments.tcc.mode | - | |
- | – | baventurepartners.tcc.mode | - | |
Biotech funding, drug development support, and investment in life sciences. | – | sofinnova.com | - | |
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | merck.com | Kenilworth, United Kingdom | |
Takeda Pharmaceuticals is engaged in developing innovative medicines globally. | 1781 | takeda.com | Tokyo, Japan | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States | |
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States |
Investor details for Pfizer
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pfizer
1482 people are tracked at Pfizer (766 in leadership, 12 in board & advisors, 704 in team); the tracked headcount is 2,404.
| Name | Role | Group |
|---|---|---|
James Farrelly | VP - R&d Digital Platform Lead | Leadership |
John Harrold | Senior Director Of Pharmacometrics | Leadership |
Tomas Kaplan | Director - Commercial Strategy & Innovation (csi) | Leadership |
Sue Diviney | VP & Office of the Ombuds Lead | Leadership |
Roger Luebbe | Director/controller US Sterile Injectable Network | Leadership |
Andrew Muratore | VP & Assistant General Counsel, Mergers & Acquisitions, And Chief Counsel, Pfizer Ventures | Leadership |
Michael Comeaux | Director Product Integrity Corporate Compliance Global Security | Leadership |
Dave Boyd | Project Director Technology Support | Leadership |
Sriram Krishnaswami | Head, R&d Portfolio And Innovation | Leadership |
Michael Hovanyetz | Senior Director, Commercial Enterprise Solutions | Leadership |
Jon Ross | Director Site Supply Operations, North Creek | Leadership |
Torres Ernesto | Director, Physical Risk Mitigation, Global Security | Leadership |
Angela Wasunna Rwiliriza | Chief Counsel, Corporate Affairs, Policy And Privacy | Leadership |
William McDaniel | Director/team Leader, External Supply - Biotech Emerging Markets | Leadership |
Don Desantis | Director Salesforce Enablement | Leadership |
Luiz Arantes | Vice President U.s. Specialty Care Medical Lead | Leadership |
Veronica Garcia | Director, Business Relationship Manager | Leadership |
Waqas Mahmood | Global Procurement Manager (pakistan And Japan)- Business Engagement Partner & Chief Of Staff | Leadership |
Lidia Fonseca | EVP & Chief Digital & Technology Officer | Leadership |
Bhagyashree Khunte | Senior Director | Leadership |
1462 more people are available in the full profile.
Complete people profiles for Pfizer
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pfizer
5 dated milestones of Pfizer across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Pfizer is founded.
- Funding First funding round.
- Funding Latest funding round, Post-IPO, of $1.0B.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Pfizer.
Competitors of Pfizer
Pfizer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Regeneron Pharmaceuticals and MorphoSys, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| incyte.com | 1991 | Wilmington, United States | – | 1,387 | Small molecules are developed for cancer and skin disease treatments. | |
| regeneron.com | 1988 | Tarrytown, United States | – | 13,450 | Antibodies are developed for treating cancer, eye, and inflammatory diseases. | |
| morphosys.com | 1992 | Planegg, Germany | – | 732 | Therapeutic antibodies for cancer and other diseases are developed. | |
| annexonbio.com | 2011 | San Francisco, United States | $256M | 80 | Developer of antibodies to treat complement-mediated neurodegenerative diseases | |
| alxoncology.com | 2015 | Burlingame, United States | $123.02M | 59 | ALX Oncology is focused on advancing cancer treatment therapies. | |
| ventyxbio.com | 2018 | Encinitas, United States | $165.3M | 79 | Therapeutics for autoimmune diseases are developed by the company. | |
| ascendispharma.com | 2007 | Hellerup, Denmark | $108.7M | 573 | Long-acting prodrug therapies are developed for endocrine and rare diseases. | |
| strandtx.com | 2017 | Cambridge, United States | $103.14M | 47 | mRNA therapeutics platform is provided for multi-functional treatments. |
Detailed competitors of Pfizer
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pfizer
The website of Pfizer (seagen.com) receives about 1.1K visits a month and ranks #7,340,146 among all websites worldwide, #6,979 in Biotechnology and Pharmaceuticals.
- Monthly visits1.1K
▼ 67.1% vs previous month
- Global rank#7,340,146
among all websites
- Category rank#6,979
Health · Biotechnology and Pharmaceuticals
- Bounce rate78%
- Pages per visit1.3
- Average visit2 min 11 sec
- DevicesDesktop 100% · Mobile 0%
Websites whose visitors overlap most with Pfizer. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| seattlegenetics.com | 100% | – | – | View details | |
hospitalsiriolibanes.org.br | hospitalsiriolibanes.org.br | 44% | – | #187,831 | – |
Latest news on Pfizer
Complete news archive for Pfizer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Pfizer
10 companies that operate in the same segment as Pfizer (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pfizer
Pfizer was founded in 1998.
Pfizer is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Pfizer has 2,404 employees.
Annual revenue of Pfizer is $1.96B as on Dec 31, 2022.
Pfizer is established as one of the worlds premier biopharmaceutical companies, focusing on the development of innovative medicines and vaccines. The company is engaged in areas such as oncology, internal medicine, inflammation, immunology, and vaccines. Solutions are provided to address chronic diseases, cancer, and widespread health threats through extensive research and clinical trials. Significant resources are dedicated to oncology, with over 50 programs and 80 clinical trials globally. The commitment is maintained to improve healthcare access and outcomes across diverse populations and regions.
Pfizer's top competitors include Moderna, BeiGene and Strand Therapeutics.
Pfizer offers Oncology Treatments, Vaccines, and Internal Medicine Therapies.
Pfizer has 10 investors. Key investors include Merck, Pfizer, J P Morgan, Takeda Pharmaceuticals, and T. Rowe Price.
Pfizer operates through Pfizer Inc..
Yes. Pfizer was acquired by Pfizer in March 2023.